A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Morgan Stanley Technology, Media & Telecom Conference 2026 March 3, 2026 12:15 PM ESTCompany ParticipantsEric Lefkofsky ...

Philip Nadeau TD Cowen, Research Division. Good morning, and welcome once again to TD Cowen's 46th Annual Healthcare Conference. I'm Phil Nadeau, one of the biotech analysts here ...

Cancer begins when mutations in specific genes override the body’s built-in controls on cell division, allowing rogue cells ...

Earnings call Hansa Biopharma reported Q4 2025 product sales of SEK 61.1M, up 139% YoY, and full-year revenues of SEK 222.3M, up 46%. The company closed a SEK 671.5M equity round, submitted its U.S.

Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.

Rybrevant Faspro is a subcutaneous co-formulation of amivantamab, a bispecific EGFR-directed and MET receptor-directed antibody, and hyaluronidase.

Vertex Pharmaceuticals (NASDAQ:VRTX) management emphasized revenue growth, expanding product diversification, and multiple late-stage pipeline milestones while reviewing fourth-quarter and full-year ...

Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses in blood vessels - one inflammatory and one protective. This protein, a ...

Discover why we stop scratching. Researchers identify spinal cord neurons that signal when an itch is satisfied, offering hope for new chronic itch treatments.